Trial Profile
The Relation of GnRH Treatment to QTc Interval in Transgender Female Youth: A Time Series Study
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Histrelin (Primary) ; Leuprorelin (Primary)
- Indications Dysphoria
- Focus Adverse reactions
- 21 Dec 2018 Status changed from recruiting to discontinued.
- 15 Mar 2017 New trial record